Florida Supreme Court to review stem cell law
The Florida, USA, Attorney General and newly-elected Republican Governor-elect Charlie Crist have asked the state's Supreme Court to review a proposed constitutional amendment that would require Florida to spend $200.0 million over 10 years on embryonic stem-cell research.
Floridans for Stem Cell Research and Cures, the campaigning organization which has been collecting petition signatures to force a referendum in 2008, is reported to have obtained 10% more than the 600,000 signatures necessary for the popular ballot procedure.
If the Florida Supreme Court rules that the proposal covers one issue and is "accurate and clear," it is expected to approve that the measure appears on ballot papers in two years, on the day of the 2008 presidential election, where it could become a major local issue.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
Free
7 day trial access
- All the news that moves the needle in pharma and biotech
- Exclusive features, podcasts, interviews, data analyses and commentary from our global network of life sciences reporters.
- Receive The Pharma Letter daily news bulletin, free forever.
Become a subscriber
£820
Or £77 per month
- Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
- Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
- Daily roundup of key events in pharma and biotech.
- Monthly in-depth briefings on Boardroom appointments and M&A news.
- Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Today's issue
Company Spotlight
Copyright © The Pharma Letter 2025 | Headless Content Management with Blaze